CM Wealth Advisors’s BioLife Solutions BLFS Stock Holding History

CM Wealth Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,993	Closed	-$557K	–	195
2023 Q1	$557K	Buy	+30,993	New	+$697K	0.11%	238

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CM Wealth Advisors's BLFS Position: Q2 2023 in Review

CM Wealth Advisors sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 30,993 shares — an estimated $557K sold.

CM Wealth Advisors first reported a position in BLFS in Q1 2023 and held it in 1 quarter. The position peaked at $557K in Q1 2023. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

CM Wealth Advisors reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
CM Wealth Advisors sold 30,993 BioLife Solutions shares in Q2 2023, an estimated $557K.
CM Wealth Advisors first reported a position in BioLife Solutions in Q1 2023 and held it in 1 quarter.
CM Wealth Advisors's BioLife Solutions position peaked at $557K in Q1 2023.
156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on CM Wealth Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.